Invitae Corporation
NVTA
Pozycja w akcjach
#35741
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Cena akcji
$0.016
Ostatnia synchronizacja: 2024-03-11
Kapitalizacja rynkowa
$3.27M
Zmiana (1 dzień)
-5.33%
Zmiana (1 rok)
3,100.00%
Kraj
US
Handel Invitae Corporation (NVTA)
Kategoria
Healthcare
Historia ceny akcji dla Invitae Corporation (NVTA)
Najwyższa cena zamknięcia: $0.00 dnia 2024-05-01
Najniższa cena zamknięcia: $0.10 dnia 2022-02-01
Najniższa cena zamknięcia: $0.10 dnia 2022-02-01
Historia cen akcji firmy Invitae Corporation od 2022 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2024 | -86.45% |
| 2023 | -72.05% |
| 2022 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.47 | 51.65% |
CN
|
|
| $177.93 | 21.98% |
US
|
